Peng Zou

Peng Zou

Auto-generated profile, based on publicly available information

Peng Zou

Department of Neurosurgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2013 in BMC Cancer
Verified
Journal Article
Open access
PDF file
PZPeng Zhao
Peng Zhao
PZPeng Zou
Peng Zou
LZLin Zhao
Lin Zhao
WYWei Yan
Wei Yan
CKChunsheng Kang
Chunsheng Kang
YYYongping You
Yongping You
Genetic variations in DNA double-strand break repair genes can influence the ability of a cell to repair damaged DNA and alter an individual’s susceptibility to cancer. We studied whether polymorphisms in DNA double-strand break repair genes are associated with an increased risk of glioma development. We genotyped 10 potentially functional single nucleotide polymorphisms (SNPs) in 7 DNA double-strand break repair pathway genes (XRCC3, BRCA2, RAG1, XRCC5, LIG4, XRCC4 and ATM) in a case–control study including 384 glioma patients and 384 cancer-free controls in a Chinese Han population. Genotypes were determined using the OpenArray platform. In the single-locus analysis there was a significant association between gliomas and the LIG4 rs1805388 (Ex2 +54C>T, Thr9Ile) TT genotype (adjusted OR, 3.27; 95% CI, 1.87-5.71), as well as the TC genotype (adjusted OR, 1.62; 95% CI, 1.20-2.18). We also found that the homozygous variant genotype (GG) of XRCC4 rs1805377 (IVS7-1A>G, splice-site) was associated with a significantly increased risk of gliomas (OR, 1.77; 95% CI, 1.12-2.80). Interestingly, we detected a significant additive and multiplicative interaction effect between the LIG4 rs1805388 and XRCC4 rs1805377 polymorphisms with an increasing risk of gliomas. When we stratified our analysis by smoking status, LIG4 rs1805388 was associated with an increased glioma risk among smokers. These results indicate for the first time that LIG4 rs1805388 and XRCC4 rs1805377, alone or in combination, are associated with a risk of gliomas.

5 January 2012 in BMC Cancer
Verified
Journal Article
Open access
PDF file
PZPeng Zou
Peng Zou
AGAihua Gu
Aihua Gu
GJGuixiang Ji
Guixiang Ji
LZLin Zhao
Lin Zhao
PZPeng Zhao
Peng Zhao
ALAilin Lu
Ailin Lu
The association between the TERT rs2736100 single nucleotide polymorphism (SNP) and cancer risk has been studied by many researchers, but the results remain inconclusive. To further explore this association, we performed a meta-analysis.

22 December 2012 in BMC Cancer
Verified
Journal Article
Open access
PDF file
PZPeng Zhao
Peng Zhao
LZLin Zhao
Lin Zhao
PZPeng Zou
Peng Zou
ALAilin Lu
Ailin Lu
NLNing Liu
Ning Liu
Tao JiangTao Jiang
Tao Jiang
The oxidative stress mechanism is of particular interest in the pathogenesis of glioma, given the high rate of oxygen metabolism in the brain. Potential links between polymorphisms of antioxidant genes and glioma risk are currently unknown. We therefore investigated the association between polymorphisms in antioxidant genes and glioma risk.

1 September 2012 in BMC Cancer
Verified
Journal Article
Open access
PDF file
PCPin Chen
Pin Chen
LZLin Zhao
Lin Zhao
PZPeng Zou
Peng Zou
HXHaitao Xu
Haitao Xu
ALAilin Lu
Ailin Lu
PZPeng Zhao
Peng Zhao
Background: ABCG2, also known as BCRP, is a half ATP-binding cassette (ABC) transporter that localizes to plasma membranes. Recently, a number of studies have investigated the relationship between the C421A polymorphism in ABCG2 and cancer risk in multiple populations and various types of cancers; however, this relationship remains unclear. Therefore, we performed a meta-analysis to further explore this association. Methods: The meta-analysis incorporated 10 studies involving a total of 3593 cases and 5875 controls. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated based on the date extracted from the studies to evaluate the strength of association. We also analyzed the heterogeneity and sensitivity of each report and the publication bias of the studies. Results: Overall, our results showed that there appeared to be a significant association between the ABCG2 C421A polymorphism and decreased cancer susceptibility (heterozygote-AC versus CC: OR = 0.759, 95%CI = 0.620-0.930; dominant effects model-AA/AC versus CC: OR = 0.771, 95%CI = 0.634-0.938; additive effects model-A allele versus C allele: OR = 0.809, 95%CI = 0.687-0.952). Similarly, decreased cancer risk was also found after stratification of the SNP data by cancer type, ethnicity and source of controls in heterozygote model, dominant effects model and additive effects model. Conclusions: We found that the ABCG2 C421A polymorphism is a protective factor for developing cancer. The same relationship was found when the studies were stratified by cancer type, ethnicity and source of controls.

13 February 2014 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
WZWei Zhao
Wei Zhao
YBYusong Bian
Yusong Bian
WZWei Zhu
Wei Zhu
PZPeng Zou
Peng Zou
GTGuotai Tang
Guotai Tang